[Peripheral mechanisms of action of oxatriazolium-5-olate derivative 3-(3-[1,2,4]-triazolo)oxatriazolium-5-olate in spontaneously hypertensive rats]

Eksp Klin Farmakol. 2012;75(8):11-4.
[Article in Russian]

Abstract

It is shown that 3-(3-[1,2,4]-triazolo)-oxatriazolium-5-olate (azasidnon-6) can act directly on the vascular wall of isolated segments of caudal ventral artery of SHR rats. Using heme-dependent soluble guanyl cyclase inhibitor 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), it has been found that one of the possible mechanisms of azasidnon-6 vasodilatory action includes heme-dependent activation of a soluble form of guanylate cyclase.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Arteries / drug effects*
  • Guanylate Cyclase / antagonists & inhibitors
  • Guanylate Cyclase / metabolism
  • Heme / metabolism
  • Male
  • Nitric Oxide / metabolism
  • Nitroprusside / pharmacology
  • Oxadiazoles / pharmacology
  • Phenylephrine / pharmacology
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Rats, Wistar
  • Tail / blood supply
  • Tissue Culture Techniques
  • Triazoles / pharmacology*
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*
  • Vasodilator Agents / pharmacology*

Substances

  • 1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one
  • 3-(3-(1,2,4)-triazolo)-oxatriazolium-5-olate
  • Oxadiazoles
  • Quinoxalines
  • Triazoles
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Nitroprusside
  • Phenylephrine
  • Nitric Oxide
  • Heme
  • Guanylate Cyclase